Can amiodarone cause a rash?

Can Amiodarone Cause Rash?

Yes, amiodarone commonly causes dermatologic adverse effects including photosensitivity reactions that present as rash, and less commonly can cause serious skin reactions including vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, and erythema multiforme. 1, 2

Primary Dermatologic Manifestations

The most common skin-related adverse effect is photosensitivity, which occurs in a significant proportion of patients receiving amiodarone therapy 1. This presents as:

• Burning, stinging, redness, and swelling that develops immediately after sun exposure
• Primarily triggered by UV-A wavelengths (350-380 nm)
• Can progress to bluish skin discoloration in sun-exposed areas with extended and recurrent exposure 1, 3
• The discoloration resolves over several months after amiodarone discontinuation 1

Research demonstrates that photosensitivity may occur in nearly all patients treated with amiodarone, suggesting this is a phototoxic rather than photoallergic reaction 3. One study found all 10 patients treated with amiodarone developed similar photosensitivity reactions.

Serious Cutaneous Reactions

While less common, amiodarone can trigger severe and potentially life-threatening skin reactions:

• Stevens-Johnson syndrome (reported in FDA labeling and clinical guidelines) 2
• Toxic epidermal necrolysis (sometimes fatal) 2
• Erythema multiforme 2
• Leukocytoclastic vasculitis presenting as palpable purpura 4, 5
• Exfoliative dermatitis 2

The FDA drug label specifically documents these serious reactions, and there have been postmarketing reports of injection site reactions including pain, erythema, edema, pigment changes, cellulitis, necrosis, and skin sloughing 2.

Clinical Management Algorithm

For all patients starting amiodarone:

1. Counsel patients to use sunblock and cover exposed skin when outdoors - this is a standard recommendation in clinical guidelines 1
2. Monitor for development of rash or skin changes at regular intervals
3. Distinguish photosensitivity reactions (dose-related, sun-exposed areas) from serious hypersensitivity reactions

If rash develops:

• Assess distribution (sun-exposed vs. generalized)
• Evaluate for systemic symptoms (fever, mucosal involvement, blistering)
• For simple photosensitivity: reinforce sun protection, consider dose reduction if severe
• For serious reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis, vasculitis): immediately discontinue amiodarone unless patient is at high risk for life-threatening arrhythmia recurrence

Important Caveats

The incidence of dermatological complications with prolonged amiodarone use reaches nearly 75% according to various sources 6, though most are reversible after drug discontinuation. However, these reactions are often misdiagnosed or overlooked despite their high frequency 6.

Critical distinction: While photosensitivity and pigmentation changes rarely necessitate drug discontinuation, serious cutaneous reactions like Stevens-Johnson syndrome require immediate cessation of therapy. The challenge lies in balancing dermatologic toxicity against the drug's life-saving antiarrhythmic properties, particularly since amiodarone is typically reserved for refractory, life-threatening arrhythmias 1.

The dermatologic effects, while usually not life-threatening, have a significant impact on patient quality of life 6, which should factor into shared decision-making about continuing therapy.